home of the INTERNATIONAL ATHEROSCLEROSIS SOCIETY
 |  |  | |  

Clinical Trials
IAS Prevention Guideline plus relevant cardiovascular guidelines from other organizations
Previous and future meetings sponsored by the IAS, the IAS member societies, or relevant affiliated organizations
Current and prior publications that have been sponsored by the IAS, including previous IAS newsletters
Distinguished Fellows of the IAS
Slides available through the IAS, Lorenzini Foundation, and other sites.
IAS monthly newsletter sent by email to all IAS members
Monthly summary of the key literature in the atherosclerosis field provided each month to all IAS members.
The IAS offers fellowships to young investigators to study in major laboratories
Important websites related to atherosclerosis and related diseases
Computer based algorithms for 10-year risk assessment for cardiovascular disease.
Organizations affiliated with the IAS.

IAS 2016 St. Petersburg, Russia

June 2-4, 2016

Symposium of the
International Atherosclerosis Society
St. Petersburg, Russia

FINAL REPORT

Abstract Book

ISA 2018 Toronto, Canada

June 9-15, 2018

XVIII International Symposium on Atherosclerosis
Toronto, Canada

Fellowship Awards
Winners 2016


Blake Cochran
Sydney, Australia


Ingo Hilgendorf
Frieburg, Germany


Yosdel Soto
Havana, Cuba


Winner Reports
Winner 2015 - Hagit Hochner
Winner 2014 - Amanda Foks
Winner 2014 - Nordin Hanssen
Winner 2014 - Marco Busnelli
last updated: September 30, 2016 

ATTENTION! To access some of the content on athero.org you must be a registered user and you must log on.
You can use the interface on the right side of this page to either log on or to register.
  FROM THE IAS PRESIDENT'S DESK

Obesity and Atherosclerosis

This month I would like to address the issue of obesity and atherosclerosis. Obesity predisposes to diabetes, disorders of plasma lipids, and hypertension and thus to the development of atherosclerotic diseases. Previous studies of obesity with respect to morbidity have revealed that the extent of obesity is not the major determinant of obesity-related metabolic and cardiovascular diseases. Rather, it is how the fat is distributed that underlies the development of these diseases.

Read more


  IAS SEVERE FH PANEL
IAS Consensus Statement “Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolemia Panel”

The International Atherosclerosis Society (IAS) is proud to announce the publication on the definition of severe FH and the implications for clinical management in The Lancet Diabetes and Endocrinology. The IAS Severe FH Panel, made of 25 internationally renowned experts and chaired by Dr. Raul Santos, worked with the objective of characterizing the severe FH phenotype and made recommendations on how to stratify CVD risk and to whom to prescribe the novel lipid lowering treatments. These recommendations will contribute to improved daily clinical practice and better management of FH patients.

To download the full text, which is open access, please link to and register at http://dx.doi.org/10.1016/S2213-8587(16)30041-9 (Published online May 27, 2016). For more information about The Lancet, please visit The Lancet Homepage at www.thelancet.com.

  IAS - OSLA Collaboration in the MENA Region
The IAS and OSLA are happy to announce that the second IAS-OSLA Course of the series on "Lipid Metabolism and Cardiovascular Risk" held in Muscat, Oman, on 22-26 February has been extremely successful and has attracted 35 participants from 17 countries from the MENA Region including many of the GCC countries, and Africa. As in 2015 this series of residential courses aims to increase the knowledge and experience of early- to mid-career English-speaking practicing clinicians interested in the management of lipid disorders. This unique series has also been successful in linking local, regional, and international leaders in the field of lipid management.
For more information on the 2016 residential IAS-OSLA Course please click here where you can find the Scientific Program, Slide Library, Faculty List, Participants List, Group Photo.

  IAS Commentaries

  Meeting and Educational Activity Highlights
To view all highlights, please click here

  Acknowledgements
The IAS wishes to thank all the supporters which have generously offered grants to the IAS for the development of its many activities and in support of its mission:
Aegerion Pharmaceuticals, Amgen, Inc., Amgen (Europe) GmbH, Daiichi Sankyo Co., Ltd., Fondazione Giovanni Lorenzini, OSLA - Oman Society of Lipids and Atherosclerosis, Otsuka Pharmaceutical Co., Ltd.,Pfizer, Sanofi and Regeneron, and Weill Cornell Medical College


Disclaimer - Cookie policy
This site is optimised for a min. 1024 x 768 pixels resolution

REGISTERED USER
USER ID


PASSWORD




Remember my password


Forgot your password?
Click here

First-time user?
Click here

WHO IS IAS

The International Atherosclerosis Society (IAS), incorporated in 1979, promotes, at an international level, the advancement of science, research and teaching in the field of atherosclerosis and related diseases.

IAS Newsletter Editors & Website Editorial Board

Editor-in-Chief
Scott M. Grundy, MD, PhD
Dallas, TX, USA

Associate Editors
Stefano Bellosta
Milan, Italy

Emanuela Folco
Milan, Italy

Ann Jackson
Houston, TX, USA

Commentary & Newsletter Editor
Yelonda Williams
(Dallas, TX, USA)

Elena Colombo
(Milan, Italy)